药物开发 药物开发
1Merck & Co., Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
研究人员在临床前模型中确定了Trem2依赖的化学激素生物标志物签名,验证了其对Trem2疗法的潜力. 这个签名显示了对神经退行性疾病治疗反应监测的前景.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前正在开发Trem2 (Triggering Receptor Expressed on Myeloid cells 2) 功能增强疗法,以调节治疗疾病的免疫反应.
- 识别可靠的生物标志物对于推进这些免疫刺激,疾病修饰策略至关重要.
研究的目的:
- 开发药理工具来刺激和剖析Trem2通路信号.
- 为了识别和验证一个保存的化学基因签名作为Trem2活动的生物标志物.
- 评估这些生物标志物在神经退行症临床前模型中的可翻译性.
主要方法:
- 开发了用于选择性Trem2通路刺激和信号分析的药理学工具.
- 在多个细胞系统中确定了一种保存的化学激素分泌特征.
- 在使用多重免疫测试的粉样蛋白病理学,陶病症和脱髓化病例的小鼠模型中验证了基因基因生物标志物.
主要成果:
- 在不同的小鼠模型中,一个强大的Trem2-依赖的化学生物标志物签名被持续上调.
- 使用Trem2抗体的药理验证表明,在野生类型和斑块负担的小鼠中,依赖于剂量的大脑化学激素反应.
- 这种反应在Trem2缺乏的小鼠中是缺失的,这证实了Trem2在微质中的信号传导的特异性诱导.
结论:
- 该研究确定了新的生物标志物和对微质Trem2通路的功能性见解.
- 这些发现为转化生物标志物策略提供了框架,以支持Trem2疗法的临床开发.
- 经过验证的基因基因生物标志物可以作为Trem2向药物的药理学终点.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
01:28Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
01:10In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K